Healthways Company Profile (NASDAQ:TVTY)

Tivity Health, Inc., formerly Healthways, Inc., is focused targeted population health for those aged 50 and older. The Company offers three programs: SilverSneakers senior fitness, Prime fitness and WholeHealth Living. The SilverSneakers senior fitness program is offered to members of Medicare Advantage, Medicare Supplement, and Group Retiree plans. The Company also offers Prime fitness, a fitness facility access program, through commercial health plans, employers and insurance exchanges. Its national network of fitness centers delivers both SilverSneakers and Prime fitness. As of December 31, 2016, the Company's fitness networks encompassed approximately 16,000 participating locations and more than 1,000 alternative locations that provide classes outside of traditional fitness centers. As of December 31, 2016, the Company's WholeHealth Living network included over 88,000 complementary, alternative, and physical medicine practitioners to serve individuals through health plans.

What is Healthways' stock symbol?

Healthways trades on the NASDAQ under the ticker symbol "TVTY."

How were Healthways' earnings last quarter?

Healthways, Inc. (NASDAQ:TVTY) issued its quarterly earnings data on Thursday, July, 27th. The company reported $0.41 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.38 by $0.03. The business earned $138.90 million during the quarter, compared to the consensus estimate of $138.15 million. Healthways had a net margin of 17.30% and a return on equity of 29.81%. The firm's revenue was up 11.1% compared to the same quarter last year. View Healthways' Earnings History.

What guidance has Healthways issued on next quarter's earnings?

Healthways issued an update on its FY17 earnings guidance on Thursday, July, 27th. The company provided EPS guidance of $1.55-1.58 for the period, compared to the Thomson Reuters consensus estimate of $1.55. The company issued revenue guidance of $550-558 million, compared to the consensus revenue estimate of $554.51 million.

Where is Healthways' stock going? Where will Healthways' stock price be in 2017?

6 equities research analysts have issued 1-year price objectives for Healthways' shares. Their forecasts range from $35.00 to $46.00. On average, they anticipate Healthways' stock price to reach $41.33 in the next twelve months. View Analyst Ratings for Healthways.

What are analysts saying about Healthways stock?

Here are some recent quotes from research analysts about Healthways stock:

2. Cantor Fitzgerald analysts commented, "1Q17 results considered impressive. Revenue of $141 million (+11.9% y/y) was above FactSet consensus expectations of $136.3 million and our estimate of $135 million. In the quarter, SilverSneakers visits of 24 million were in line with expectations. Importantly, the mix of visits was more skewed toward members who pay the company per visit fee, resulting in higher revenue. Management expects the mix of visits to normalize for the rest of 2017. Additionally, in its Prime Fitness program, TVTY had a higher-than-expected increase in member pay enrollment. Adjusted EBITDA margin of 22.6% improved from last year, driven by higher revenue and cost controls. We note that the average cost per visit in the SilverSneakers program was lower than expected. Technology infrastructure costs were also lower than anticipated. Adjusted EPS of $0.42 were well-above FactSet consensus of $0.34 and our estimate of $0.32 and benefited from a lower-than-expected tax rate." (4/28/2017)

Who sold Healthways stock? Who is selling Healthways stock?

Healthways' stock was sold by a variety of institutional investors in the last quarter, including Nationwide Fund Advisors, Lbmc Investment Advisors LLC, Pinebridge Investments L.P., Capstone Asset Management Co. and Aperio Group LLC. Company insiders that have sold Healthways stock in the last year include Conan Laughlin, Glenn Hargreaves, Mary Flipse and Mary Jane England. View Insider Buying and Selling for Healthways.

Who bought Healthways stock? Who is buying Healthways stock?

Healthways' stock was acquired by a variety of institutional investors in the last quarter, including Lord Abbett & CO. LLC, Neuberger Berman Group LLC, Chartwell Investment Partners LLC, Eaton Vance Management, Russell Investments Group Ltd., Piedmont Investment Advisors LLC, Riggs Asset Managment Co. Inc. and Riverhead Capital Management LLC. Company insiders that have bought Healthways stock in the last two years include Conan Laughlin, Donato Tramuto, Lee Shapiro and Robert J Greczyn Jr. View Insider Buying and Selling for Healthways.

How do I buy Healthways stock?

Shares of Healthways can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Healthways' stock price today?

One share of Healthways stock can currently be purchased for approximately $39.35.

MarketBeat's community ratings are surveys of what our community members think about Healthways and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

MarketBeat calculates consensus ratings using the most recent rating from each brokerage that has rated a stock within the last twelve months. Since brokers often use different ratings systems, each rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings. Each stock's consensus rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months.

MarketBeat will no longer include ratings and price target data in its consensus calculation if a broker drops coverage and MarketBeat has received a report that coverage was dropped. Ratings from certain research firms that issue ratings using purely quantitative methods (such as Zacks, Vetr and ValuEngine) are not included in consensus calculations. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.